ZWZheng-Dong Wu

Zheng-Dong Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zheng-Dong Wu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • VEGF +405G/C (rs2010963) polymorphisms and digestive system cancer risk: a meta-analysis

    by Qing Guo, Sheng-Bin Dai, Feng Shen, Di Yu, Shu-Tong Shen, Qu Zhang, Jun-Xing Huang, Zheng-Dong Wu

    Vascular endothelial growth factor (VEGF) polymorphisms, specifically +405G/C (rs2010963), reportedly influence the risk for various digestive cancers. However, the consequences of these polymorphisms remain controversial and ambiguous. Therefore, we performed a meta-analysis of 11 studies with VEGF +405G/C genotyping on 2,862 patients and 3,028 controls using the random effects model. We obtained a pooled odds ratio (OR) of 1.04 (95 % confidence interval (CI) = 0.86–1.26) for the recessive genetic model, 1.07 (95 % CI = 0.81–1.42) for the dominant genetic model, 1.09 (95 % CI = 0.81–1.47) for the homozygote comparison, and 1.03 (95 % CI = 0.83–1.27) for the heterozygote comparison. In the subgroup analysis of the recessive model, the OR was 1.20 (95 % CI = 1.02–1.40) in colorectal cancer. These results show that VEGF +405G/C polymorphisms are unlikely to be a major determinant of susceptibility to digestive cancer. Furthermore, the subgroup analysis of recessive model indicates that VEGF +405G/C polymorphisms increase the risk for colorectal cancer.


    • 1 August 2009
      • Vol. 38  (8) , 552-4

    [Immunophenotype analysis on neoplastic cells in bone marrow and peripheral blood of angioimmunoblastic T-cell lymphoma].

    by Li-Xin Zhang, Jun Ye, Tao-Hong Lu, Gai-Nü Jiang, Wei Xiao, Xue-Jun Zhu, Ya-Bao Chen, Tong-Jing Xing, Zheng-Dong Wu, Jun-Xing Huang